Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1/2 Study of VX15/2503 in Children, Adolescents, or Young Adults With Recurrent or Relapsed Solid Tumors

NCT03320330 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT03320330
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03320330 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1/2 Study of VX15/2503 in Children, Adolescents, or Young Adults With Recurrent or Relapsed Solid Tumors
Lead sponsor
Children's Oncology Group
Phase
Phase 1/2
Overall status
Completed
Start date
January 31, 2018
Completion date
June 30, 2024
Enrollment
26 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent malignant solid neoplasm, recurrent osteosarcoma, refractory malignant solid neoplasm, refractory osteosarcoma